| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Medtronic plc (NYSE: MDT)
MDT Technical Analysis
5
| As on 9th Jun 2023 MDT STOCK Price closed @ 83.73 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 96.39 & Strong Sell for SHORT-TERM with Stoploss of 104.52 we also expect STOCK to react on Following IMPORTANT LEVELS. |
MDTSTOCK Price
| Open | 83.14 | Change | Price | % |
| High | 83.86 | 1 Day | 0.63 | 0.76 |
| Low | 82.61 | 1 Week | 0.97 | 1.17 |
| Close | 83.73 | 1 Month | -7.65 | -8.37 |
| Volume | 3302200 | 1 Year | -17.92 | -17.63 |
| 52 Week High 113.09 | 52 Week Low 76.13 | ||||
NYSE USA Most Active Stocks
| DDR | 15.44 | -4.46% |
| NIO | 7.73 | -0.77% |
| TWTR | 53.70 | 0.66% |
| CVNA | 19.07 | -21.30% |
| BACA-U | 302.00 | 0.67% |
| PLTR | 15.02 | -1.12% |
| F | 13.74 | 1.18% |
| CS | 0.89 | 1.14% |
| RPAI | 13.15 | -3.17% |
| AUY | 5.85 | -0.68% |
NYSE USA Top Gainers Stocks
NYSE USA Top Losers Stocks
| MDT Daily Charts |
MDT Intraday Charts |
Whats New @ Bazaartrend |
MDT Free Analysis |
|
|
MDT Important Levels Intraday
| RESISTANCE | 86.14 |
| RESISTANCE | 85.37 |
| RESISTANCE | 84.89 |
| RESISTANCE | 84.41 |
| SUPPORT | 83.05 |
| SUPPORT | 82.57 |
| SUPPORT | 82.09 |
| SUPPORT | 81.32 |
MDT Forecast April 2024
| 4th UP Forecast | 102.85 |
| 3rd UP Forecast | 96.72 |
| 2nd UP Forecast | 92.93 |
| 1st UP Forecast | 89.14 |
| 1st DOWN Forecast | 78.32 |
| 2nd DOWN Forecast | 74.53 |
| 3rd DOWN Forecast | 70.74 |
| 4th DOWN Forecast | 64.61 |
MDT Weekly Forecast
| 4th UP Forecast | 93.19 |
| 3rd UP Forecast | 90.16 |
| 2nd UP Forecast | 88.28 |
| 1st UP Forecast | 86.41 |
| 1st DOWN Forecast | 81.05 |
| 2nd DOWN Forecast | 79.18 |
| 3rd DOWN Forecast | 77.30 |
| 4th DOWN Forecast | 74.27 |
MDT Forecast2024
| 4th UP Forecast | 158 |
| 3rd UP Forecast | 134.18 |
| 2nd UP Forecast | 119.46 |
| 1st UP Forecast | 104.73 |
| 1st DOWN Forecast | 62.73 |
| 2nd DOWN Forecast | 48 |
| 3rd DOWN Forecast | 33.28 |
| 4th DOWN Forecast | 9.46 |
Medtronic plc ( NYSE USA Symbol : MDT )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
MDT Business Profile
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiovascular Portfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves; percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, percutaneous angioplasty balloons, and products to treat superficial venous diseases in the lower extremities. The Medical Surgical Portfolio segment offers surgical products, including surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases. The Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The Diabetes Operating Unit segment offers insulin pumps and consumables, and continuous glucose monitoring systems. The company was founded in 1949 and is headquartered in Dublin, Ireland. Address: 20 On Hatch, Dublin, Ireland, 2
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service